A real world study evaluating the effectiveness of erenumab compared with oral preventive medications (OPM) among migraine patients: A US Claims Database Study
Latest Information Update: 04 Jun 2021
At a glance
- Drugs Antimigraines (Primary) ; Erenumab (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 04 Jun 2021 New trial record
- 22 Apr 2021 Results presented at the 73rd Annual Meeting of the American Academy of Neurology